Newest first. 5.2k questions across 107 tags.
Second wave of shedding, nine months in, and I have been told by two people in strong terms that switching from tirzepatide to semaglutide will fix it because…
Six lyophilised research vials, ordered with "cold shipping". Arrived after six days in transit. Inside: a bubble mailer, a 250 g gel pack at room temperature and…
I split one vial and sent halves to two independent laboratories. Purity came back 98.1% and 99.4%. Both sent chromatograms. Both look competent. The 1.3-point gap is…
What I am working with: 98.2% · Medutest · 96.8%. This is not behaving the way I expected and I want to understand the discrepancy before I act on it. I have…
The specifics, since they change the answer: orforglipron · Tianjin. I would like to set this up properly once, rather than adjust it repeatedly. My budget is real…
What I am working with: an HPLC purity test · dulaglutide. I have used one of these for a while and I am considering switching, which requires a reason. What I care…
Details up front: mazdutide · tirzepatide. I have used one of these for a while and I am considering switching, which requires a reason. What I care about is…
Details up front: 4 °C · dulaglutide. I would rather be corrected now than propagate something wrong. I am specifically not interested in a testimonial; I am…
Setup, so nobody has to ask: WWB · retatrutide. I would rather be corrected now than propagate something wrong. I am specifically not interested in a testimonial; I…
Stated plainly: Janoshik · FGP. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to disagree, which…
Details up front: 2–8 °C · retatrutide. I would rather be corrected now than propagate something wrong. I am specifically not interested in a testimonial; I am…
The case in front of me: survodutide · 20 mg/mL · three weeks. I want to know whether there is evidence behind this or only repetition. I have checked the obvious…
The case in front of me: 6.67 mg/mL · liraglutide. These are treated as interchangeable and I do not think they are. If both are acceptable I would like to know that,…
This is my second independent submission on material from the same supplier. I have read the obvious sources and they disagree with each other, so I would rather ask…
For reference: oral semaglutide · three weeks · 40 °C. I am at the decision point and I would rather think it through than improvise. I would rather spend money on…
Setup, so nobody has to ask: method section · CPC. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I am reasonably…
What I am working with: 12.5 mg · eight weeks · nausea. The empirical answer seems settled. The explanation does not. If the honest answer is that nobody knows, I…
The method section is present, which is unusual enough that I want to make use of it. I suspect the honest answer is that it depends, in which case I would like to…
Numbers first: a GLP-1 receptor agonist · 10 mg/mL. I can find plenty of assertions about this and almost no reasoning, which is usually a sign that nobody has…
The case in front of me: dizziness · five · liraglutide. I can find plenty of assertions about this and almost no reasoning, which is usually a sign that nobody has…
Conditions: racemisation · dulaglutide · VendorInvestigate. I can find plenty of assertions about this and almost no reasoning, which is usually a sign that nobody…
The material is still sealed, so I have not committed to anything yet. This is a planning question. I know what my options are; I do not know how to weigh them. What…
Details up front: 95.2% · Janoshik · 97.1% · Medutest. I want to know what the trade-off actually is rather than which option is fashionable. I would rather have a…
I have three data points across nine months, which I hope is enough to see a trend. This should be a straightforward calculation and I keep getting two different…